How do you treat Kaposi sarcoma in an immunodeficient patient? Which therapy is commonly used to treat Kaposi sarcoma? Kaposi sarcoma (KS) is the most common malignancy seen in patients with HIV infection. In the current era of treatment, KS is generally identified as a late manifestation of HIV infection, occurring when immunosuppression is severe so, KS-associated morbidity and mortality rates have increased in these patients. Kaposi sarcoma (KS) was first described by the Viennese dermatologist Moritz Kaposi more than a century ago.
KS is used to study various aspects of carcinogenesis, including viral oncogenesis, angiogenesis, and cancer immunology. Kaposi sarcoma is a vascular neoplasm composed of endothelium-lined vascular spaces and spindle-shaped cells. It is a low-grade vascular tumor that involves the skin, mucosa, and viscera. KS is the most prevalent malignancy among…
